GGrantIndex
Sort

64,565 grants matching drug discovery

Collaborative Research: MFB: Ultra-Fast Development of Portable Small Molecule Sensor-Actuators

$1,318,297
Ian Wheeldon · University Of California-Riverside · · FY2021 · MPS

Overall Critique

$1,318,190
Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2016 · CA

Pathogen-specific drug targets for weaponized bacteria

$1,317,962
Rockefeller University · U19 · FY2004 · AI

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal

$1,317,799
Matthew G Dorsey · University Of California, San Francisco · U19 · FY2017 · AI

Next-Generation Medical Resequencing of Gout Disease Genes in the ARIC Cohort

$1,317,671
James E. Hixson · University Of Texas Hlth Sci Ctr Houston · RC2 · FY2009 · HG

Machine learning approaches to predict Acetylcholinesterase inhibition and model applications

$1,317,335
Sean Ekins · Collaborations Pharmaceuticals, Inc. · R44 · FY2025 · ES

Molecular Mechanisms of TGF-beta Signaling Pathway

$1,317,304
Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Molecular Definition of Brain Circuits Controlling Addiction

$1,317,201
Nathaniel Heintz · Rockefeller University · P30 · FY2016 · DA

NATURAL INHIBITORS OF CARCINOGENESIS

$1,316,851
Purdue University West Lafayette · P01 · FY2003 · CA

Nipah & Hendra Virus Nonhuman Primate Model & Therapeutics Development

$1,316,712
Thomas William Geisbert · Boston University Medical Campus · U01 · FY2009 · AI

Psoriasis Center of Research Translation

$1,316,550
Kevin D Cooper · Case Western Reserve University · P50 · FY2020 · AR

Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas

$1,316,397
Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2015 · HL

Center for Interventional Oncology

$1,316,258
Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2021 · CA

PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD

$1,316,216
Samuel V Alworth · Acurastem, Inc. · R44 · FY2019 · NS

ANTICANCER DRUGS ACTIVE AGAINST CELL CYCLE AND SIGNAL PA

$1,316,121
University Of Arizona · U19 · FY2004 · CA

Genetic Studies of Alzheimer Disease in Koreans

$1,315,853
Lindsay A. Farrer · Boston University Medical Campus · U01 · FY2021 · AG

Molecular Pathogenesis of Neoplasia

$1,315,532
Russell Lonser · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,315,513
Kenneth R Chien · Massachusetts General Hospital · U01 · FY2009 · HL

Biochemical Assay Core

$1,315,250
John Damon Chodera · Sloan-Kettering Inst Can Research · U19 · FY2022 · AI

Structure-based discovery of allosteric ligands for G Protein Coupled Receptors

$1,314,924
Brian K Kobilka · Stanford University · U19 · FY2013 · GM

Natural Inhibitors of Carcinogenesis

$1,314,629
Purdue University West Lafayette · P01 · FY2005 · CA

The cBioPortal for Cancer Genomics

$1,314,519
Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2017 · CA

MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN)

$1,314,109
Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2021 · DA

NINDS Human Cell and Data Repository (U24)

$1,313,946
Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2022 · NS

Screening Core

$1,313,870
James Robert Bostwick · University Of Alabama At Birmingham · U19 · FY2015 · AI